Safety and tolerability of OROS® hydromorphone ER in adults with chronic noncancer and cancer pain: Pooled analysis of 13 studies

  • Martin E. Hale, MD, Mark S. Wallace, MD, Donald R. Taylor, MD, Michael Kutch, MS, Srinivas Nalamachu, MD
  • Journal of Opioid Management, September 2012, Weston Medical Publishing
  • DOI: 10.5055/jom.2012.0130

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Mr Michael Kutch